Osiris Therapeutics
Columbia
About Osiris Therapeutics
Osiris Therapeutics, Inc. is a stem cell company, which focuses on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular, orthopedic and wound healing markets. The company operates its business through two segments: Therapeutics and Biosurgery segment. The Therapeutics segment focuses on developing biologic stem cell drug candidates from readily available and non-controversial sources.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 501 – 1,000
- Estimated revenue: $100K – $500K
- Total funding: $95.0M
- Funding stage: M&A
- Last round: Series Unknown (Jul 2018)
- Ticker: nasdaq:OSIR
- Website: osiris.com
- Phone: 4432834382
Industries & Categories
Biotechnology, Marketing, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/osiris-therapeutics-630002 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.